Medicines and Driving Personalized Medicine and Medical Liability
Physicians establish which medicines should be administered for the benefit of patients. The system of categorization for medicines and driving developed by the International Council on Alcohol, Drugs and Traffic Safety (ICADTS) and research groups within the European project DRUID (Driving Under the Influence of Drugs, alcohol and medicines) would allow the prescribing doctor to look for safer alternatives within a specific therapeutic class. A prime and exemplificative medico-legal case of driving under the influence of psychotropic medications is presented, analyzing the responsibilities of each participant: the patient, the general and specialized physician, and the driving licensing authorities. It is necessary to establish guidelines relating to the prescription of psychoactive medications, to be shared and adopted by all of the parties involved. The point of reference is that of Personalized Medicine, a paradigm which also entails the personalization of therapy, including a careful evaluation of the social sphere and impact on the community.
- 2.Dewar RE, Olson PL (2007) Human factors in traffic safety, 2nd edn. Lawyers & Judges Pub Co, Tucson, AZGoogle Scholar
- 10.Monteiro SP, van Dijk L, Verstraete AG, Alvarez FJ, Heissing M, de Gier JJ (2012) Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey. BMC Public Health 12:59. doi: 10.1186/1471-2458-12-59CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Moller HJ, World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive D (2013) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 14:334–85. doi: 10.3109/15622975.2013.804195
- 12.Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ, World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive D (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3:5–43CrossRefGoogle Scholar
- 20.Ravera S, Monteiro SP, de Gier JJ, van der Linden T, Gomez-Talegon T, Alvarez FJ, Partners DPW (2012) A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project. Br J Clin Pharmacol 74:920–931. doi: 10.1111/j.1365-2125.2012.04279.xCrossRefPubMedPubMedCentralGoogle Scholar
- 22.Ferrara SD, Snenghi R, Boscolo M (2006) Idoneità alla Guida & Sostanze Psicoattive. Linee Guida Metodologico-Accertative e Criteriologico-Valutative – Società Italiana Medicina Legale e delle Assicurazioni (SIMLA). Piccin Editore PadovaGoogle Scholar